Jennifer Lawrence will be back on our screens this month in Netflix's Don't Look Up, the latest satire to emerge from director Adam McKay. But despite the streaming giant snapping up that film, someone has swooped in to produce their next collaboration, with Apple splashing cash to back Bad Blood.
This is one that has been in the works for a few years now, since at least 2016 when Lawrence was attached to the film. It'll focus on "disruptive" medical company Theranos, founded by Elizabeth Holmes (the role Lawrence will play). Launched in 2003, Holmes claimed that Theranos would revolutionise blood testing by using just a pinprick of blood, as opposed to the usual method of a syringe or two. The company was the darling of Silicon Valley when it started, securing a $9 billion valuation, with Holmes herself worth around $4.5 billion given her 50 per cent stake. But following accusations that its testing was inaccurate and there had been problems in the lab, the company is under investigation, the valuation has plummeted and Holmes and her executives are defending themselves. Things have since turned even more sour for Holmes and Theranos with a fraud trial.
McKay is basing the current script on John Carreyrou's book Bad Blood: Secrets And Lies In A Silicon Valley Startup, which was published in 2018. Don't Look Up, meanwhile, will be in select UK cinemas from Friday before it lands on Netflix's servers on 24 December. Merry Crisismass!